New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
10:57 EDTGSK, CBST, MITK, CWH, SSYSHigh option volume stocks: GSK CBST MITK CWH SSYS
News For GSK;CBST;MITK;CWH;SSYS From The Last 14 Days
Check below for free stories on GSK;CBST;MITK;CWH;SSYS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2014
08:06 EDTGSKProsonix, Mylan enter licensing deal for generic version of Flixotide, Flovent
Subscribe for More Information
06:32 EDTGSKPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 14, 2014
16:58 EDTCWHCommonWealth REIT entered into forbearance agreements
Subscribe for More Information
10:02 EDTSSYSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:40 EDTGSKGlaxoSmithKline paid bribes to Polish doctors to promote Seretide, BBC says
Subscribe for More Information
06:08 EDTSSYSStratasys on growth for earnings expectations in 2014, says JPMorgan
After meeting with the company's CFO, JPMorgan believes Stratasys is on track to meet growth and earnings expectations in 2014. The firm views the stock as attractively valued following the recent pullback and keeps an Overweight rating on the name with a $130 price target. Note Stratasys shares were initiated at Buy this morning at Goldman Sachs.
06:00 EDTSSYSStratasys initiated with a Buy at Goldman
Target $146.
05:53 EDTCWHStocks with implied volatility movement; SDS CWH
Subscribe for More Information
April 13, 2014
20:20 EDTSSYS3D Systems, other 3-D printing stocks could fall further, Barron's says
Subscribe for More Information
April 10, 2014
11:42 EDTGSKReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
April 8, 2014
11:03 EDTCBST, GSKPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
08:46 EDTGSKTeva announces first approval, launch of generic Lovaza capsules in the U.S.
Teva (TEVA) announces the approval of the generic equivalent to Lovaza in the United States. Teva believes it is first-to-file and thus far is the only company to receive an approval from FDA. Teva plans to commence shipping immediately. Lovaza Capsules, marketed by GlaxoSmithKline (GSK), had annual sales of approximately $1.1B in the United States, according to IMS data as of December 2013.
07:22 EDTGSKCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
17:04 EDTSSYSStratasys new 3D printing material simulates polypropylene
Subscribe for More Information
14:18 EDTGSKGlaxoSmithKline reports 14.1% stake in Applied Genetic Technologies
Subscribe for More Information
06:22 EDTSSYS3-D stocks off to a rough start in 2014, WSJ reports
3-D stocks are off to a rough start this year with 3D Systems (DDD) down 40% and Stratasys (SSYS) down about 19%, the Wall Street Journal reports, but adds that some 3-D stocks remain priced at 50-70 times projected 2014 earnings. Reference Link
April 6, 2014
16:23 EDTGSKGlaxoSmithKline investigates bribery allegations in Iraq, WSJ says
GlaxoSmithKline is investigating allegations of bribery by employees in Iraq, says the Wall Street Journal, citing emails reviewed by the publication. Reference Link
April 4, 2014
08:31 EDTSSYSStratasys acquires Interfacial Solutions
Subscribe for More Information
07:57 EDTSSYSDeloitte Corporate advising Solid Conceps on sale to Stratasys
Subscribe for More Information
06:29 EDTGSKGlaxoSmithKline cuts China employees amid probe, WSJ reports
According to a source, as it deals with a bribery probe in Beijing, GlaxoSmithKline is cutting employees in China, the Wall Street Journal reports. It is unclear how many of Glaxo's 7,000 employees in China have been let go. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use